Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.

Future Neurology
Silva Markovic-PleseInderjit Singh

Abstract

Statins as inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A reductase are widely used as cholesterol-lowering drugs. Recent studies provide evidence that the anti-inflammatory activity of statins, which is independent of their cholesterol-lowering effects, may have potential therapeutic implications for neuroinflammatory diseases such as multiple sclerosis (MS), Alzheimer's disease and brain tumors, as well as traumatic spinal cord and brain injuries. Studies with animal models of MS suggest that, in addition to immunomodulatory activities similar to the ones observed with approved MS medications, statin treatment also protects the BBB, protects against neurodegeneration and may also promote neurorepair. Although the initial human studies on statin treatment for MS are encouraging, prospective randomized clinical studies will be required to evaluate their efficacy in the larger patient population.

References

Feb 1, 1993·Annals of Neurology·J W PrineasE S Cho
Oct 19, 1996·Lancet·C J VaughanB M Buckley
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
May 21, 1999·Multiple Sclerosis : Clinical and Laboratory Research·D MatuseviciusH Link
Dec 28, 1999·JAMA : the Journal of the American Medical Association·J C LaRosaS Vupputuri
Dec 29, 1999·Nature Medicine·D PittC S Raine
Aug 10, 2000·Journal of the American College of Cardiology·D FerroF Violi
Dec 2, 2000·Nature Medicine·B KwakF Mach
Dec 13, 2000·Neurology·B GranR Martin
Dec 21, 2000·Current Atherosclerosis Reports·J A Farmer
Aug 29, 2001·Neurology·M FilippiUNKNOWN Eurpoean/Canadian Glatiramer Acetate Study Group
Nov 10, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·M Takemoto, J K Liao
Nov 21, 2001·Current Controlled Trials in Cardiovascular Medicine·Gavin J Blake, Paul M Ridker
Jan 18, 2002·The New England Journal of Medicine·Ansi ChangBruce D Trapp
Dec 13, 2002·Nature·Sandrine Etienne-Manneville, Alan Hall
Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bernard P LeungIain B McInnes
Mar 11, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·John GreenwoodPeter Adamson
Mar 12, 2003·The Journal of Experimental Medicine·Orhan AktasFrauke Zipp
Jul 17, 2003·Journal of Neurology·Armando SenaM Graça Morais
Dec 4, 2003·FEBS Letters·Kuo-Chin HuangWan-Wan Lin
Dec 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cristina CidAlberto Alcázar
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Narender NathInderjit Singh
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne McKayFoo Y Liew
Apr 7, 2004·The Journal of Clinical Investigation·David A Hafler
May 18, 2004·Lancet·Timothy VollmerInderjit Singh
Jun 16, 2004·Journal of Neuroscience Research·Ajaib Singh PaintliaInderjit Singh

❮ Previous
Next ❯

Citations

Jun 8, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Halina Bartosik-PsujekJacek Rolinski
May 10, 2012·Journal of Neurology·Christian Philipp KammHeinrich Paul Mattle
Nov 29, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Anandakumar ShunmugavelInderjit Singh
Mar 25, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Ulivieri, Cosima T Baldari
Sep 8, 2010·Expert Review of Neurotherapeutics·Rina Aharoni
Nov 30, 2010·Journal of Neuroimmunology·Ron Milo, Hillel Panitch
Aug 11, 2010·Behavioural Brain Research·Harikesh KaloniaAnil Kumar
Jun 16, 2010·Experimental Neurology·Joanne L Jones, Alasdair J Coles
Aug 23, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ZhangSilva Markovic-Plese
Oct 12, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Elizabeth A MillsYang Mao-Draayer

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
GTPases
GTPase

Software Mentioned

PRISMS
ETOMS
BENEFIT

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.